Fairlie DP - Search Results

1

Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity.

Mantzourani C, Gkikas D, Kokotos A, Nummela P, Theodoropoulou MA, Wu KC, Fairlie DP, Politis PK, Ristimäki A, Kokotos G. Mantzourani C, et al. Among authors: fairlie dp. Bioorg Chem. 2021 Sep;114:105132. doi: 10.1016/j.bioorg.2021.105132. Epub 2021 Jun 28. Bioorg Chem. 2021. PMID: 34229198

2

Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.

Glenn MP, Kahnberg P, Boyle GM, Hansford KA, Hans D, Martyn AC, Parsons PG, Fairlie DP. Glenn MP, et al. Among authors: fairlie dp. J Med Chem. 2004 Jun 3;47(12):2984-94. doi: 10.1021/jm030222i. J Med Chem. 2004. PMID: 15163181

3

New cysteine derivatives with antiproliferative activity on melanoma cells.

Lucke AJ, Boyle GM, Parsons PG, Fairlie DP. Lucke AJ, et al. Among authors: fairlie dp. Med Chem. 2006 Mar;2(2):123-32. doi: 10.2174/157340606776056124. Med Chem. 2006. PMID: 16787361

4

Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid.

Kahnberg P, Lucke AJ, Glenn MP, Boyle GM, Tyndall JD, Parsons PG, Fairlie DP. Kahnberg P, et al. Among authors: fairlie dp. J Med Chem. 2006 Dec 28;49(26):7611-22. doi: 10.1021/jm050214x. J Med Chem. 2006. PMID: 17181145

5

A refined agonist pharmacophore for protease activated receptor 2.

Barry GD, Suen JY, Low HB, Pfeiffer B, Flanagan B, Halili M, Le GT, Fairlie DP. Barry GD, et al. Among authors: fairlie dp. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5552-7. doi: 10.1016/j.bmcl.2007.08.026. Epub 2007 Aug 16. Bioorg Med Chem Lett. 2007. PMID: 17765542

6

Inhibitors selective for HDAC6 in enzymes and cells.

Gupta PK, Reid RC, Liu L, Lucke AJ, Broomfield SA, Andrews MR, Sweet MJ, Fairlie DP. Gupta PK, et al. Among authors: fairlie dp. Bioorg Med Chem Lett. 2010 Dec 1;20(23):7067-70. doi: 10.1016/j.bmcl.2010.09.100. Epub 2010 Oct 12. Bioorg Med Chem Lett. 2010. PMID: 20947351

7

Structures of peptide agonists for human protease activated receptor 2.

Stoermer MJ, Flanagan B, Beyer RL, Madala PK, Fairlie DP. Stoermer MJ, et al. Among authors: fairlie dp. Bioorg Med Chem Lett. 2012 Jan 15;22(2):916-9. doi: 10.1016/j.bmcl.2011.12.029. Epub 2011 Dec 13. Bioorg Med Chem Lett. 2012. PMID: 22209488

8

Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2.

Xu W, Lim J, Goh CY, Suen JY, Jiang Y, Yau MK, Wu KC, Liu L, Fairlie DP. Xu W, et al. Among authors: fairlie dp. J Chem Inf Model. 2015 Oct 26;55(10):2079-84. doi: 10.1021/acs.jcim.5b00500. Epub 2015 Oct 12. J Chem Inf Model. 2015. PMID: 26445028

9

Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships.

Singh R, Reed AN, Chu P, Scully CC, Yau MK, Suen JY, Durek T, Reid RC, Fairlie DP. Singh R, et al. Among authors: fairlie dp. Bioorg Med Chem Lett. 2015 Dec 1;25(23):5604-8. doi: 10.1016/j.bmcl.2015.10.038. Epub 2015 Oct 23. Bioorg Med Chem Lett. 2015. PMID: 26522948

10

Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.

Yau MK, Liu L, Lim J, Lohman RJ, Cotterell AJ, Suen JY, Vesey DA, Reid RC, Fairlie DP. Yau MK, et al. Among authors: fairlie dp. Bioorg Med Chem Lett. 2016 Feb 1;26(3):986-991. doi: 10.1016/j.bmcl.2015.12.048. Epub 2015 Dec 17. Bioorg Med Chem Lett. 2016. PMID: 26725028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page